GSK - GlaxoSmithKline PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GSK is currently covered by 11 analysts with an average price target of $22.82. This is a potential upside of $-10.88 (-32.28%) from yesterday's end of day stock price of $33.7.

GlaxoSmithKline PLC ADR's activity chart (see below) currently has 118 price targets and 88 ratings on display. The stock rating distribution of GSK is 38.89% HOLD, 11.11% SELL and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.44% with an average time for these price targets to be met of 357.53 days.

Highest price target for GSK is $44, Lowest price target is $39.5, average price target is $22.82.

Most recent stock forecast was given by EMMANUEL PAPADAKIS from DEUTSCHE BANK on 15-Nov-2024. First documented stock forecast 28-Jul-2014.

Currently out of the existing stock ratings of GSK, 7 are a HOLD (38.89%), 2 are a SELL (11.11%), 9 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8 days ago
(15-Nov-2024)

0/13 (0%)

$-19.36 (-47.20%)

Buy

$39.5

$5.8 (17.21%)

$53

11 days ago
(12-Nov-2024)

2/5 (40%)

$4 (11.27%)

368

Buy

$22.07

4 months 15 days ago
(08-Jul-2024)

0/14 (0%)

$-16.41 (-42.65%)

Hold

$44

$10.3 (30.56%)

$18.72

10 months ago
(23-Jan-2024)

1/14 (7.14%)

$5.42 (14.05%)

107

Hold

$19.52

$-14.18 (-42.08%)

$18.9

1 years 3 months 9 days ago
(14-Aug-2023)

0/3 (0%)

$-14.59 (-42.77%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?

On average it took 357.53 days on average for the stock forecasts to be realized with a an average price target met ratio 19.44

Which analyst has the current highest performing score on GSK (GlaxoSmithKline PLC ADR) with a proven track record?

STEVE SCALA

Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?

Steve Scala works at TD COWEN and has 11 price targets and 5 ratings on GSK

Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?

Mark Purcell with highest potential upside - $10.3

Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?

Eric Le Berrigaud with lowest potential downside - -$22.45

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?